This summer the FDA greenlit ketamine for treatment for ALS for the company PharmaTher (Source: https://psychedelicspotlight.com/fda-green-lights-ketamine-treatment-als/ ).
This bodes really well for other psychedelic medicine and ketamine treatment companies such as one of my picks Levitee Labs ( $LVT.C $LVTTF )
$LVT has used an aggressive M&A regimen to acquire mental health and addiction treatment centres that focus on psychedelic medicines and therapies.
Currently, $LVTs portfolio includes
- Levitee Clinics (five addiction & pain treatment clinics in Alberta)
- Levitee Pharmacies (three substance use disorder, mental health, and pain specialized pharmacies)
- BlockMD, (electronic-prescriptions tech company)
- and Earth Circle Organics (supplements and superfood products wholesaler)
Right now $LVT is trading at just $0.29/share (slightly down today) which is a steal IMO espically considering the growing acceptance of ketamine treatments among regulatory bodies and consumers alike.